Latest Breaking News On - Heart failure therapeutics - Page 4 : comparemela.com

THT 2024 Late-Breaking Clinical Science Announced

The complete list of late-breaking clinical science to be presented at THT 2024: Technology and Heart Failure Therapeutics is now available online. An internat

United statesTufts medical centerNew yorkCleveland clinicWilliamt abrahamGabriel sayerDaniel burkhoffDavidm kayeJoann lindenfeldSanjivj shahNavink kapurJerryd estepSeanp pinneyUlrichp jordeSteveno marxAdamb greenbaum

Cardiovascular Research Foundation (CRF)

Cardiovascular Research Foundation (CRF)News, press releases, and expert sources for journalists in science, medicine & business

Medtech innovation forumCardiovascular research foundationHeart failure therapeuticsTranscatheter cardiovascular therapeuticsExcellence topHeartpoint globalTank innovation competitionAnnual pulseCity galaFogarty innovationTech innovation forumCardiovascular research foundation crfCience newsCience headlinesResearch newsCience news releases

Tenax Therapeutics Announces Oral Presentation of Levosimendan for the Treatment of PH-HFpEF at THT 2024

Tenax Therapeutics Announces Oral Presentation of Levosimendan for the Treatment of PH-HFpEF at THT 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJohn frauncesmanaging directorlifesciSanjiv shahChris giordanoSanjivj shahNasdaq stock marketOrion corporationResearch for the bluhm cardiovascular instituteTenax therapeutics incCardiovascular research foundation technologyCardiovascular research foundationHeart failure therapeuticsHeart failureStone endowed professorBluhm cardiovascular instituteNorthwestern university feinberg school

THT 2024 Late-Breaking Clinical Science Announced

The complete list of late-breaking clinical science to be presented at THT 2024: Technology and Heart Failure Therapeutics is now available online. An internat

United statesNew yorkTufts medical centerCleveland clinicLiviu kleinFiras zahrWh wilson tangKanikap modyStavrosg drakosSnehalr patelKamile cerlinskaite bajoreSitaramesh emaniNir urielDavid ian feldmanDeya alkhatibDaniel burkhoff

Tenax Therapeutics Announces Oral Presentation of Levosimendan for the Treatment of PH-HFpEF at THT 2024

29.02.2024 - Dr. Sanjiv Shah, a renowned, global expert in the treatment of HFpEF and PH-HFpEF, will present data highlighting the use of levosimendan for the treatment of pulmonary hypertension due to heart failure with preserved ejection fraction (PH-HFpEF) . Seite 1

United statesSanjiv shahChris giordanoSanjivj shahResearch for the bluhm cardiovascular instituteCardiovascular research foundation technologyTenax therapeutics incHeart failureStone endowed professorBluhm cardiovascular instituteNorthwestern university feinberg schoolCardiovascular research foundationHeart failure therapeuticsConcurrent sessionWestin boston seaportChief executive officer